Phreesia, Inc. Stock News

Phreesia (PHR) delivered earnings and revenue surprises of 13.64% and 2.73%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?

Phreesia, Inc. (NYSE:PHR ) Q2 2023 Results Conference Call September 7, 2022 5:00 PM ET Company Participants Balaji Gandhi - Senior Vice President, Investor Relations Chaim Indig - Chief Executive Off

Phreesia (PHR) delivered earnings and revenue surprises of 10.10% and 3.04%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?

Healthcare ecosystem management platform developer Phreesia (NYSE: PHR) stock is sunk (-40%) on the year.

The consensus price target hints at a 25.5% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate

Phreesia, Inc. (NYSE:PHR ) Q1 2023 Earnings Conference Call June 2, 2022 5:00 PM ET Company Participants Balaji Gandhi - Senior Vice President, Investor Relations Chaim Indig - Chief Executive Officer

Phreesia (PHR) delivered earnings and revenue surprises of 9.17% and 1.49%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

April quarter earnings continue this week in Needham's broader Enterprise Software space with Salesforce, Inc (NYSE: CRM), UiPath, Inc (NYSE: PATH), Phreesia Inc (NYSE: PHR), and Veeva System

Phreesia (PHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Phreesia (PHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of -5% and 0.24%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Privia Health (PRVA) delivered earnings and revenue surprises of 500% and 5.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -40% and 1.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock